Erin Taylor, PhD, MSPH
Erin is the principal investigator on a SHARE-funded project to inform federal and state policy-makers seeking to assure access to affordable care for patients who use specialty drugs. The project will compare and contrast specialty drug coverage across states, analyze the impact of state marketplaces, and model the impacts of coverage characteristics on the affordability of care for marketplace enrollees at risk for high medical spending.
Erin Taylor is an associate policy researcher at the RAND Corporation. Her research interests include pharmaceutical issue areas such as specialty drug coverage, medication adherence, and Medicare Part D, as well as quality measurement programs in the broader Medicare Program. She has extensive experience with Medicare Parts A, B, and D claims data, and since coming to RAND has participated in a number of projects related to Medicare quality measurement programs. She is currently co-leader of a task exploring ways to strengthen the Medicare Part C & D STAR Rating program, and is on the RAND team working with the Health Services Advisory Group on the 2015 National Impact Assessment for CMS. She has also worked on a project evaluating workplace wellness programs and conducting analyses related to the ACO CAHPS survey.
Other Professional Roles
Prior to coming to RAND, Taylor worked in the Office of Legislation at the Centers for Medicare & Medicaid Services. She earned her Ph.D. in health economics from the Wharton School at the University of Pennsylvania, and her M.S.P.H. from the University of North Carolina at Chapel Hill. For her dissertation, she used Medicare claims data to estimate the effect of specialty tier placement for expensive prescription drugs on utilization and enrollment for high-risk beneficiaries enrolled in Medicare Part D